Table 1.
Mental health condition | Essential psychotropic medicine | Income level | |||
---|---|---|---|---|---|
Low (N = 20) (%) | Lower middle (N = 41) (%) | Upper middle (N = 37) (%) | High (N = 14) (%) | ||
Psychotic disorders | Chlorpromazine | 100 | 90 | 97 | 100 |
LAI fluphenazine | 60 | 78 | 76 | 79 | |
Haloperidol | 85 | 90 | 100 | 93 | |
Risperidone | 35 | 61 | 14 | 100 | |
Clozapine | 25 | 29 | 62 | 71 | |
Depressive disorders | Amitriptyline | 90 | 82 | 100 | 100 |
Fluoxetine | 65 | 76 | 95 | 100 | |
Mood disorders | Carbamazepine | 90 | 88 | 100 | 100 |
Lithium carbonate | 60 | 59 | 87 | 93 | |
Valproic acid | 80 | 82 | 89 | 100 | |
Anxiety | Diazepam | 95 | 98 | 100 | 100 |
OCD | Clomipramine | 60 | 49 | 57 | 57 |
OCD, Obsessive-Compulsive Disorder; LAI, long-acting injectable.